Send to

Choose Destination
See comment in PubMed Commons below

Long-acting insulin analogues in the treatment of diabetes mellitus type 2: Executive summary of final report A05-03, Version 1.1.


Institute for Quality and Efficiency in Health Care: Executive Summaries [Internet]. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2005-.
2009 Feb 26.


The aims of this research were: the benefit assessment of long-term therapy with an LAIA (insulin glargine or insulin detemir) compared with treatment with a longer-acting insulin based on human insulin; the benefit assessment of LAIAs compared with each other, in each case in patients with diabetes mellitus type 2. The main focus of the assessment was on patient-relevant therapy goals. The benefit assessment was based on the comparison of the desired and undesired effects of the individual drugs.

© IQWiG (Institute for Quality and Efficiency in Health Care).

LinkOut - more resources

Full Text Sources

Other Literature Sources

PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Health
    Loading ...
    Write to the Help Desk